Effects of Irbesartan on the Growth and Differentiation of Adipocytes in Obese Zucker Rats

Authors

  • Clara Di Filippo,

    1. Department of Experimental Medicine, Section of Pharmacology L. Donatelli, and Second University of Naples, Naples, Italy
    2. “Excellence Centre for Cardiovascular Disease,” Second University of Naples, Naples, Italy
    Search for more papers by this author
  • Enrico Lampa,

    1. Department of Experimental Medicine, Section of Pharmacology L. Donatelli, and Second University of Naples, Naples, Italy
    2. “Excellence Centre for Cardiovascular Disease,” Second University of Naples, Naples, Italy
    Search for more papers by this author
  • Elisabetta Tufariello,

    1. Department of Experimental Medicine, Section of Pharmacology L. Donatelli, and Second University of Naples, Naples, Italy
    Search for more papers by this author
  • Pasquale Petronella,

    1. Department of General and Emergency Surgery, Second University of Naples, Naples, Italy
    Search for more papers by this author
  • Fulvio Freda,

    1. Department of General and Emergency Surgery, Second University of Naples, Naples, Italy
    Search for more papers by this author
  • Annalisa Capuano,

    1. Department of Experimental Medicine, Section of Pharmacology L. Donatelli, and Second University of Naples, Naples, Italy
    2. “Excellence Centre for Cardiovascular Disease,” Second University of Naples, Naples, Italy
    Search for more papers by this author
  • Michele D'Amico

    Corresponding author
    1. Department of Experimental Medicine, Section of Pharmacology L. Donatelli, and Second University of Naples, Naples, Italy
    2. “Excellence Centre for Cardiovascular Disease,” Second University of Naples, Naples, Italy
    • Department of Experimental Medicine, Section of Pharmacology, Second University of Naples, Via Costantinopoli 16, 80138 Naples, Italy. E-mail: michele.damico@unina2.it

    Search for more papers by this author

  • The costs of publication of this article were defrayed, in part, by the payment of page charges. This article must, therefore, be hereby marked “advertisement” in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

Abstract

Objective: The aim of this study was to evaluate the effects of the selective angiotensin receptor 1 antagonist irbesartan on the growth and differentiation of the adipocytes in obese Zucker fa/fa rats.

Research Methods and Procedures: Obese Zucker fa/fa rats were treated by oral route for 3 weeks with irbesartan at doses of 3–10-30 mg/kg per day. The adipocyte differentiation was evaluated by analyzing tissue samples of white (retroperitoneal) or brown (interscapular) adipose tissue for the presence of peroxisome proliferator activated receptor γ, leptin, and the activity of glycerol-3-phosphate dehydrogenase.

Results: This study showed that the treatment of obese Zucker fa/fa with irbesartan effectively reduced the differentiation of adipocytes within brown (interscapular) and white (retroperitoneal) adipose tissue. In fact, irbesartan significantly (p < 0.01) and dose-dependently reduced the tissue levels of leptin, peroxisome proliferator activated receptor γ, and the activity of the enzyme glycerol-3-phoshate dehydrogenase accepted markers of adipocyte differentiation. None of the tested doses of irbesartan affected these markers in non-obese rats.

Discussion: The antagonism of the angiotensin receptor 1 receptors with irbesartan reduces the adipogenic activity of angiotensin II in obese Zucker rats, with the endpoint being reduction of the growth and differentiation of the adipocytes within the adipose tissue.

Ancillary